Zai Lab (ZLAB) Consolidated Net Income (2020 - 2026)
Zai Lab (ZLAB) reported Consolidated Net Income of -$51.0 million for Q1 2026, down 5.24% on a YoY basis from -$53.8 million in Q1 2025, and down 1.12% sequentially from -$50.4 million in Q4 2025.
Zai Lab (ZLAB) Consolidated Net Income (2020 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 7 years of Consolidated Net Income data on file, last reported at -$51.0 million in Q1 2026.
- For the quarter ending Q1 2026, Consolidated Net Income fell 5.24% year-over-year to -$51.0 million; the trailing twelve-month figure through Mar 2026 stood at -$178.1 million (up 29.35% YoY), and the FY2025 full-year result was -$175.5 million, up 31.73% from the prior year.
- Consolidated Net Income declined to -$51.0 million in Q1 2026, from -$50.4 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of -$36.0 million in Q3 2025 to a low of -$161.2 million in Q3 2022.
- A 5-year average of -$74.2 million and a median of -$61.8 million in 2022 frame the typical range for Consolidated Net Income.
- Peak annual rise in Consolidated Net Income reached 70.77% in 2022, while the deepest fall reached 67.78% in 2022.
- Tracing ZLAB's Consolidated Net Income over 5 years: stood at -$61.8 million in 2022, then sank by 54.49% to -$95.4 million in 2023, then advanced by 14.4% to -$81.7 million in 2024, then surged by 38.29% to -$50.4 million in 2025, then declined by 1.12% to -$51.0 million in 2026.
- Business Quant data shows ZLAB's Consolidated Net Income at -$51.0 million in Q1 2026, -$50.4 million in Q4 2025, and -$36.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | -50.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.98 Mn |
| Dec 31, 2025 | -50.41 Mn |
| Sep 30, 2025 | -35.96 Mn |
| Jun 30, 2025 | -40.73 Mn |
| Mar 31, 2025 | -48.44 Mn |
| Dec 31, 2024 | -81.68 Mn |
| Sep 30, 2024 | -41.67 Mn |
| Jun 30, 2024 | -80.28 Mn |
| Mar 31, 2024 | -53.47 Mn |
| Dec 31, 2023 | -95.43 Mn |
| Sep 30, 2023 | -69.15 Mn |
| Jun 30, 2023 | -120.90 Mn |
| Mar 31, 2023 | -49.14 Mn |
| Dec 31, 2022 | -61.77 Mn |
| Sep 30, 2022 | -161.19 Mn |
| Jun 30, 2022 | -137.93 Mn |
| Mar 31, 2022 | -82.17 Mn |
| Dec 31, 2021 | -211.32 Mn |
| Sep 30, 2021 | -96.07 Mn |
| Jun 30, 2021 | -162.92 Mn |